Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
Clinical trial NCT00027261 · COMPLETED
Trial details
- NCT number
- NCT00027261
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.